Orthofix Medical Inc.
OFIX
$15.46
-$0.10-0.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.31% | 4.84% | 5.85% | 7.08% | 17.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.31% | 4.84% | 5.85% | 7.08% | 17.32% |
| Cost of Revenue | 5.32% | 5.97% | 4.56% | -1.09% | 6.05% |
| Gross Profit | 3.86% | 4.31% | 6.48% | 11.28% | 23.22% |
| SG&A Expenses | 4.87% | 2.98% | 2.70% | 0.35% | 9.34% |
| Depreciation & Amortization | -27.25% | -19.27% | -18.31% | 13.28% | 28.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.33% | 2.70% | 2.23% | -0.59% | 7.81% |
| Operating Income | 6.19% | 15.84% | 23.87% | 43.08% | 39.64% |
| Income Before Tax | -1.82% | -4.02% | -14.02% | 16.68% | 13.02% |
| Income Tax Expenses | -71.97% | -60.27% | -24.49% | -21.87% | 5.44% |
| Earnings from Continuing Operations | -0.08% | -2.67% | -13.12% | 16.78% | 12.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.08% | -2.67% | -13.12% | 16.78% | 12.66% |
| EBIT | 6.19% | 15.84% | 23.87% | 43.08% | 39.64% |
| EBITDA | 237.22% | 185.26% | 134.70% | 98.99% | 81.48% |
| EPS Basic | 3.26% | 0.85% | -8.92% | 20.46% | 19.53% |
| Normalized Basic EPS | 6.78% | 9.20% | 5.39% | 22.71% | 29.19% |
| EPS Diluted | 3.16% | 0.75% | -8.94% | 20.54% | 19.61% |
| Normalized Diluted EPS | 6.78% | 9.20% | 5.39% | 22.71% | 29.19% |
| Average Basic Shares Outstanding | 3.70% | 3.70% | 3.59% | 4.02% | 16.63% |
| Average Diluted Shares Outstanding | 3.70% | 3.70% | 3.59% | 4.02% | 16.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |